The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but we do pay a price for that we pay a financial price for that in other words it costs money to screen early and we pay potentially an emotional price from that because as we'll get to and you alluded to we have to now get into false positives and false negatives
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
you have to understand your risk appetite as an individual and you have to understand the price you're going to pay for screening because there's a couple of prices you pay the first is economic... but I think there's an even bigger cost that you have to be willing to tolerate if you go down this rabbit hole which is the cost of the false positive the emotional cost of the false positive
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.